164 related articles for article (PubMed ID: 3139428)
1. Haemodynamic, anti-anginal and anti-ischaemic effects of sublingual nitroglycerin: dose-response, duration and time of onset of action.
Nyberg G; Holmberg B
Eur J Clin Pharmacol; 1988; 34(6):561-7. PubMed ID: 3139428
[TBL] [Abstract][Full Text] [Related]
2. The time of onset of action of sublingual nitroglycerin in exercise-induced angina pectoris. A methodological study.
Nyberg G
Eur Heart J; 1985 Jul; 6(7):625-30. PubMed ID: 3930248
[TBL] [Abstract][Full Text] [Related]
3. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
[TBL] [Abstract][Full Text] [Related]
4. Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design.
Winsor T; Berger HJ
Am Heart J; 1975 Nov; 90(5):611-26. PubMed ID: 811102
[TBL] [Abstract][Full Text] [Related]
5. Effect of benazepril on myocardial ischaemia in patients with chronic stable angina pectoris.
Tzivoni D; Gottlieb S; Khurmi NS; Medina A; Gavish A; Stern S
Eur Heart J; 1992 Aug; 13(8):1129-34. PubMed ID: 1505563
[TBL] [Abstract][Full Text] [Related]
6. Onset time of action and duration up to 3 hours of nitroglycerin in buccal, sublingual and transdermal form.
Nyberg G
Eur Heart J; 1986 Aug; 7(8):673-8. PubMed ID: 3095117
[TBL] [Abstract][Full Text] [Related]
7. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
Ulvenstam G; Diderholm E; Frithz G; Gudbrandsson T; Hedbäck B; Höglund C; Moelstad P; Perk J; Sverrisson JT
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S67-73. PubMed ID: 1282179
[TBL] [Abstract][Full Text] [Related]
8. Studies on the response of nitroglycerin oral spray compared with sublingual tablets for angina pectoris patients with dry mouth. A multicenter trial.
Sato H; Koretsune Y; Taniguchi T; Fukui S; Shimazu T; Sugii M; Matsuyama T; Karita M; Hori M
Arzneimittelforschung; 1997 Feb; 47(2):128-31. PubMed ID: 9079231
[TBL] [Abstract][Full Text] [Related]
9. [Anti-anginal efficacy of oral nitroglycerin. A clinical double-blind study with dose-effect relationships].
Schneider W; Kaltenbach M; Stahl B; Bussmann WD
Dtsch Med Wochenschr; 1984 Aug; 109(31-32):1187-91. PubMed ID: 6430666
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris.
Greco R; D'Alterio D; Schiattarella M; Boccia A; Greco L; Marsico F
Am J Cardiol; 1988 Mar; 61(9):44E-51E. PubMed ID: 3126635
[TBL] [Abstract][Full Text] [Related]
11. Failure of transdermal nitroglycerin to improve chronic stable angina: a randomized, placebo-controlled, double-blind, double crossover trial.
Crean PA; Ribeiro P; Crea F; Davies GJ; Ratcliffe D; Maseri A
Am Heart J; 1984 Dec; 108(6):1494-500. PubMed ID: 6439019
[TBL] [Abstract][Full Text] [Related]
12. Nitroglycerin lingual spray: clinical efficacy and dose-response relation.
Parker JO; Vankoughnett KA; Farrell B
Am J Cardiol; 1986 Jan; 57(1):1-5. PubMed ID: 3079939
[TBL] [Abstract][Full Text] [Related]
13. Sustained high-dose nitroglycerin transcutaneous patch therapy in angina pectoris: evidence for attenuation of effect over time.
Frishman WH; Giles T; Greenberg S; Heiman M; Raffidal L; Soberman J; Laifer L; Nadelmann J; Lazar E; Strom J
J Clin Pharmacol; 1989 Dec; 29(12):1097-105. PubMed ID: 2515215
[TBL] [Abstract][Full Text] [Related]
14. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
Parker JD; Parker AB; Farrell B; Parker JO
Circulation; 1995 Feb; 91(4):973-8. PubMed ID: 7850984
[TBL] [Abstract][Full Text] [Related]
15. Does the exercise protocol matter when assessing the anti-anginal effects of drug therapy?
Patel DJ; Mulcahy D; Norrie J; Sparrow J; Wright C; Ford I; Fox KM
Eur Heart J; 1995 Dec; 16(12):1773-9. PubMed ID: 8682006
[TBL] [Abstract][Full Text] [Related]
16. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U
Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614
[TBL] [Abstract][Full Text] [Related]
17. Antianginal effects of intravenous nitroglycerin over 24 hours.
Zimrin D; Reichek N; Bogin KT; Aurigemma G; Douglas P; Berko B; Fung HL
Circulation; 1988 Jun; 77(6):1376-84. PubMed ID: 3131041
[TBL] [Abstract][Full Text] [Related]
18. Can nitroglycerin convert effort-induced angina in men into silent myocardial ischemia?
Khosla S; Coutinho NB; Megellas MM; Mukherjee D; Somberg JC
Am J Cardiol; 1995 Aug; 76(5):337-9. PubMed ID: 7639156
[TBL] [Abstract][Full Text] [Related]
19. Chronic effects of transdermal nitroglycerin in stable angina pectoris: a within-patient, placebo-controlled study.
Gibelli G; Negrini M; Bruno AM; Fiorini GL; Lambiase M; Magenta G; Corti D; Prina L; Pollavini PG; De Ponti C
Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):436-41. PubMed ID: 2509380
[TBL] [Abstract][Full Text] [Related]
20. [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris].
Bonelli J; Gazo F; Liedtke RK
Arzneimittelforschung; 1989 Nov; 39(11A):1515-7. PubMed ID: 2576203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
